Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.42 is 27% above its 1-year average of 4.27, near the high end of its 1-year range (0.00–7.40).
As of the fiscal period ended Tuesday, June 30, 2026. 15.43% below its 12-month average of 6.41.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.42.
QUICK RATIO (ACID-TEST)
5.42
QUICK RATIO (ACID-TEST) AVG TTM
6.41
QUICK RATIO (ACID-TEST) AVG 3Y
N/A
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.43%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.11
median of 692 covered companies
CURRENT VS SECTOR MEDIAN
+74.35%
vs the sector median at left
BlossomHill Therapeutics, Inc.
Market Cap
$555.16M
Quick Ratio (Acid-Test)
5.42
TTM Avg
6.41
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556.87M
Quick Ratio (Acid-Test)
1.68
TTM Avg
2.23
3Y Avg
2.63
5Y Avg
2.59
Market Cap
$558.65M
Quick Ratio (Acid-Test)
3.46
TTM Avg
4.63
3Y Avg
6.00
5Y Avg
6.13
Market Cap
$560.00M
Quick Ratio (Acid-Test)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$566.03M
Quick Ratio (Acid-Test)
2.36
TTM Avg
2.55
3Y Avg
5.33
5Y Avg
7.55
Market Cap
$567.12M
Quick Ratio (Acid-Test)
9.36
TTM Avg
2.17
3Y Avg
1.76
5Y Avg
2.63
Market Cap
$540.95M
Quick Ratio (Acid-Test)
8.95
TTM Avg
10.43
3Y Avg
5.97
5Y Avg
5.34
Market Cap
$538.58M
Quick Ratio (Acid-Test)
25.13
TTM Avg
6.17
3Y Avg
7.34
5Y Avg
19.91
Market Cap
$538.01M
Quick Ratio (Acid-Test)
8.36
TTM Avg
10.03
3Y Avg
20.35
5Y Avg
14.11
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | $555.16M | 5.42 | 6.41 | N/A | N/A |
| Nuvectis Pharma, Inc. (NVCT)vs › | $556.87M | 1.68 | 2.23 | 2.63 | 2.59 |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $558.65M | 3.46 | 4.63 | 6.00 | 6.13 |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CorMedix Inc. (CRMD)vs › | $566.03M | 2.36 | 2.55 | 5.33 | 7.55 |
| CytomX Therapeutics, Inc. (CTMX)vs › | $567.12M | 9.36 | 2.17 | 1.76 | 2.63 |
| Delcath Systems, Inc. (DCTH)vs › | $540.95M | 8.95 | 10.43 | 5.97 | 5.34 |
| Immix Biopharma, Inc. (IMMX)vs › | $538.58M | 25.13 | 6.17 | 7.34 | 19.91 |
| ProKidney Corp. (PROK)vs › | $538.01M | 8.36 | 10.03 | 20.35 | 14.11 |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $537.18M | 1.87 | 2.92 | 5.55 | 6.22 |
Quick Ratio
5.42
Excludes inventory
Current Ratio
5.42
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.42 |
| 2026-03-31 | 7.40 |
| 2025-03-31 | 0.00 |
